Financial results - PHARMIS CONSULTING SRL

Financial Summary - Pharmis Consulting Srl
Unique identification code: 17187010
Registration number: J2005000216291
Nace: 4773
Sales - Ron
948.427
Net Profit - Ron
90.329
Employees
1
Open Account
Company Pharmis Consulting Srl with Fiscal Code 17187010 recorded a turnover of 2025 of 948.427, with a net profit of 90.329 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmis Consulting Srl

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Sales - EUR 95.887 89.021 99.990 98.439 111.491 114.956 141.282 156.280 180.394 948.427
Total Income - EUR 95.901 89.037 100.022 98.444 111.528 115.004 141.464 156.303 180.668 950.974
Total Expenses - EUR 98.753 95.053 94.931 90.615 97.999 100.287 125.971 138.094 159.108 842.282
Gross Profit/Loss - EUR -2.852 -6.016 5.091 7.829 13.529 14.717 15.493 18.209 21.560 108.692
Net Profit/Loss - EUR -3.289 -6.907 4.100 6.844 12.414 13.567 14.078 16.646 17.780 90.329
Employees 4 4 0 2 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 5.7%, from 180.394 euro in the year 2024, to 948.427 euro in 2025. The Net Profit increased by 1.885 euro, from 17.780 euro in 2024, to 90.329 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmis Consulting Srl

Rating financiar

Financial Rating -
PHARMIS CONSULTING SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmis Consulting Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmis Consulting Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmis Consulting Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmis Consulting Srl - CUI 17187010

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Fixed Assets 766 127 411 362 894 715 957 516 308 3.196
Current Assets 29.869 30.941 28.577 30.487 47.595 51.290 60.104 57.978 56.181 299.878
Inventories 13.397 12.280 11.908 15.356 28.977 31.102 35.579 34.194 39.060 208.946
Receivables 2.439 8.004 8.247 7.273 9.997 11.590 14.943 17.342 11.114 40.749
Cash 14.033 10.657 8.421 7.859 8.621 8.598 9.582 6.442 6.008 50.183
Shareholders Funds 3.716 -3.253 906 7.733 20.000 27.817 35.578 37.283 39.777 208.637
Social Capital 45 44 43 42 41 40 41 40 40 200
Debts 26.919 33.879 28.081 23.116 28.489 24.188 25.484 21.210 16.712 94.437
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 1 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 299.878 euro in 2025 which includes Inventories of 208.946 euro, Receivables of 40.749 euro and cash availability of 50.183 euro.
The company's Equity was valued at 208.637 euro, while total Liabilities amounted to 94.437 euro. Equity increased by 10.772 euro, from 39.777 euro in 2024, to 208.637 in 2025.

Risk Reports Prices

Reviews - Pharmis Consulting Srl

Comments - Pharmis Consulting Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.